These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 31410540)

  • 21. Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.
    Blanc-Durand P; Van Der Gucht A; Verger A; Langen KJ; Dunet V; Bloch J; Brouland JP; Nicod-Lalonde M; Schaefer N; Prior JO
    PLoS One; 2018; 13(6):e0199379. PubMed ID: 29953478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using
    Lohmeier J; Radbruch H; Brenner W; Hamm B; Tietze A; Makowski MR
    J Nucl Med; 2023 Nov; 64(11):1683-1689. PubMed ID: 37652542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of
    Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2257-2265. PubMed ID: 28831534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of O-(2-[
    Kertels O; Kessler AF; Mihovilovic MI; Stolzenburg A; Linsenmann T; Samnick S; Brändlein S; Monoranu CM; Ernestus RI; Buck AK; Löhr M; Lapa C
    Mol Imaging Biol; 2019 Dec; 21(6):1174-1181. PubMed ID: 30977078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement.
    Rosen J; Stoffels G; Lohmann P; Bauer EK; Werner JM; Wollring M; Rapp M; Felsberg J; Kocher M; Fink GR; Langen KJ; Galldiks N
    Sci Rep; 2021 Oct; 11(1):20828. PubMed ID: 34675225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic
    Unterrainer M; Ruf V; von Rohr K; Suchorska B; Mittlmeier LM; Beyer L; Brendel M; Wenter V; Kunz WG; Bartenstein P; Herms J; Niyazi M; Tonn JC; Albert NL
    Front Oncol; 2021; 11():645316. PubMed ID: 33996563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting IDH genotype in gliomas using FET PET radiomics.
    Lohmann P; Lerche C; Bauer EK; Steger J; Stoffels G; Blau T; Dunkl V; Kocher M; Viswanathan S; Filss CP; Stegmayr C; Ruge MI; Neumaier B; Shah NJ; Fink GR; Langen KJ; Galldiks N
    Sci Rep; 2018 Sep; 8(1):13328. PubMed ID: 30190592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers.
    Skoblar Vidmar M; Doma A; Smrdel U; Zevnik K; Studen A
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma.
    Galldiks N; Stoffels G; Ruge MI; Rapp M; Sabel M; Reifenberger G; Erdem Z; Shah NJ; Fink GR; Coenen HH; Langen KJ
    J Nucl Med; 2013 Dec; 54(12):2046-54. PubMed ID: 24159047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
    Gempt J; Bette S; Ryang YM; Buchmann N; Peschke P; Pyka T; Wester HJ; Förster S; Meyer B; Ringel F
    Eur J Radiol; 2015 May; 84(5):955-62. PubMed ID: 25748815
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Suchorska B; Unterrainer M; Biczok A; Sosnova M; Forbrig R; Bartenstein P; Tonn JC; Albert NL; Kreth FW
    J Neurooncol; 2018 Sep; 139(3):721-730. PubMed ID: 29948765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous parameters based on
    Hua T; Zhou W; Zhou Z; Guan Y; Li M
    Quant Imaging Med Surg; 2021 Jan; 11(1):317-327. PubMed ID: 33392031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans.
    Albert NL; Winkelmann I; Suchorska B; Wenter V; Schmid-Tannwald C; Mille E; Todica A; Brendel M; Tonn JC; Bartenstein P; la Fougère C
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1105-14. PubMed ID: 26666239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
    Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential implementation of DSC-MR perfusion and dynamic [
    Steidl E; Langen KJ; Hmeidan SA; Polomac N; Filss CP; Galldiks N; Lohmann P; Keil F; Filipski K; Mottaghy FM; Shah NJ; Steinbach JP; Hattingen E; Maurer GD
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1956-1965. PubMed ID: 33241456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated CT Radiomics Features Could Enhance the Efficacy of
    Zhou W; Huang Q; Wen J; Li M; Zhu Y; Liu Y; Dai Y; Guan Y; Zhou Z; Hua T
    Front Oncol; 2021; 11():772703. PubMed ID: 34869011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
    Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
    J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET.
    Wang Y; Fushimi Y; Arakawa Y; Shimizu Y; Sano K; Sakata A; Nakajima S; Okuchi S; Hinoda T; Oshima S; Otani S; Ishimori T; Tanji M; Mineharu Y; Yoshida K; Nakamoto Y
    Jpn J Radiol; 2023 Nov; 41(11):1255-1264. PubMed ID: 37219717
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Unterrainer M; Galldiks N; Suchorska B; Kowalew LC; Wenter V; Schmid-Tannwald C; Niyazi M; Bartenstein P; Langen KJ; Albert NL
    J Nucl Med; 2017 Apr; 58(4):584-589. PubMed ID: 27754904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.